EXONDYS 51 ETEPLIRSEN INJECTION Trademark

Trademark Overview

On Monday, September 19, 2016, a trademark application was filed for EXONDYS 51 ETEPLIRSEN INJECTION with the United States Patent and Trademark Office. The USPTO has given the EXONDYS 51 ETEPLIRSEN INJECTION trademark a serial number of 87175636. The federal status of this trademark filing is REGISTERED as of Tuesday, May 19, 2020. This trademark is owned by Sarepta Therapeutics, Inc.. The EXONDYS 51 ETEPLIRSEN INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
exondys 51 eteplirsen injection

General Information

Serial Number87175636
Word MarkEXONDYS 51 ETEPLIRSEN INJECTION
Filing DateMonday, September 19, 2016
Status700 - REGISTERED
Status DateTuesday, May 19, 2020
Registration Number6059005
Registration DateTuesday, May 19, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 21, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"51 ETEPLIRSEN INJECTION"
Description of MarkThe mark consists of a hexagon, bisected be a swoosh, followed by the text and numeral "EXONDYS 51" over the text "(eteplirsen) Injection"; the color gray is intended to show shading or contrast only.
Goods and ServicesPharmaceutical preparations for the treatment of neuromuscular diseases and disorders
Pseudo MarkEXONDYS FIFTY ONE ETEPLIRSEN INJECTION

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 23, 2016
Primary Code005
First Use Anywhere DateThursday, March 26, 2020
First Use In Commerce DateThursday, March 26, 2020

Trademark Owner History

Party NameSarepta Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSarepta Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSarepta Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, July 22, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 19, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, April 14, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, April 11, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 7, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 31, 2020USE AMENDMENT FILED
Tuesday, March 31, 2020TEAS STATEMENT OF USE RECEIVED
Friday, September 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2019EXTENSION 5 GRANTED
Monday, September 23, 2019EXTENSION 5 FILED
Thursday, September 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 23, 2019TEAS EXTENSION RECEIVED
Saturday, April 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2019EXTENSION 4 GRANTED
Thursday, April 18, 2019EXTENSION 4 FILED
Thursday, April 18, 2019TEAS EXTENSION RECEIVED
Tuesday, October 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 12, 2018EXTENSION 3 GRANTED
Friday, October 12, 2018EXTENSION 3 FILED
Friday, October 12, 2018TEAS EXTENSION RECEIVED
Saturday, March 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 29, 2018EXTENSION 2 GRANTED
Thursday, March 29, 2018EXTENSION 2 FILED
Thursday, March 29, 2018TEAS EXTENSION RECEIVED
Friday, October 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2017EXTENSION 1 GRANTED
Wednesday, October 18, 2017EXTENSION 1 FILED
Wednesday, October 18, 2017TEAS EXTENSION RECEIVED
Tuesday, April 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 16, 2017EXAMINER'S AMENDMENT ENTERED
Monday, January 16, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 16, 2017EXAMINERS AMENDMENT E-MAILED
Monday, January 16, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, January 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 13, 2017NON-FINAL ACTION E-MAILED
Friday, January 13, 2017NON-FINAL ACTION WRITTEN
Friday, December 23, 2016ASSIGNED TO EXAMINER
Saturday, September 24, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, September 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 22, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

injection eteplirsen exondys diseases disorders neuromuscular treatment preparations pharmaceutical